Arkolith/Insider Trading/EIGR/Form 4

Apelian David

DirectorEiger BioPharmaceuticals, Inc. (EIGR) · full profile →Form 4 · filed Aug 18, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$49K
Net Open-Market Flow
-$49K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 16, 2022Sell(S)5K$9.81$49K11K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-016461) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML